Insider Transactions in Q1 2022 at Tracon Pharmaceuticals, Inc. (TCON)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+1.75%
|
$8,000
$2.7 P/Share
|
|
Mar 29
2022
|
Scott B. Brown CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
1,000
+10.39%
|
$2,000
$2.82 P/Share
|
|
Mar 21
2022
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
1,200
+0.54%
|
$2,400
$2.45 P/Share
|
|
Mar 16
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,235
+0.08%
|
$4,470
$2.2 P/Share
|
|
Jan 28
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500
+0.02%
|
$1,000
$2.2 P/Share
|
|
Jan 24
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
17,363
+0.63%
|
$34,726
$2.05 P/Share
|
|
Jan 21
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
35,000
+1.31%
|
$70,000
$2.19 P/Share
|
|
Jan 20
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
21,312
+0.57%
|
$42,624
$2.25 P/Share
|
|
Jan 19
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
23,688
+0.95%
|
$47,376
$2.24 P/Share
|